A proof of principle trial of alpha-1 antitrypsin in patients with graft versus host disease.

Trial Profile

A proof of principle trial of alpha-1 antitrypsin in patients with graft versus host disease.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 10 Jul 2013

At a glance

  • Drugs Alpha 1-antitrypsin (Primary)
  • Indications Graft-versus-host disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Jul 2013 Status changed from planning to recruiting, based on information in an Omni Bio Pharmaceutical media release.
    • 10 Jul 2013 Financial support from the University of Michigan Cancer Center and the Leukemia and Lymphoma Society has been announced by Omni Bio Pharmaceutical. The University of Michigan Cancer Center is commencing the trial as reported in an Omni Bio media release.
    • 17 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top